ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $494 | +9.3% | 24,124 | +6.1% | 0.00% | 0.0% |
| Q2 2023 | $452 | -8.1% | 22,735 | -20.8% | 0.00% | 0.0% |
| Q1 2023 | $492 | -25.3% | 28,715 | -14.8% | 0.00% | 0.0% |
| Q4 2022 | $659 | -99.9% | 33,698 | +17.4% | 0.00% | 0.0% |
| Q3 2022 | $458,000 | +16.2% | 28,710 | +0.4% | 0.00% | 0.0% |
| Q2 2022 | $394,000 | -13.4% | 28,607 | -0.2% | 0.00% | – |
| Q1 2022 | $455,000 | -27.4% | 28,657 | -0.2% | 0.00% | -100.0% |
| Q4 2021 | $627,000 | -27.0% | 28,720 | -0.0% | 0.00% | 0.0% |
| Q3 2021 | $859,000 | -65.1% | 28,723 | -48.3% | 0.00% | -66.7% |
| Q2 2021 | $2,459,000 | +80.5% | 55,511 | +80.8% | 0.00% | +50.0% |
| Q1 2021 | $1,362,000 | -19.1% | 30,700 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,684,000 | +120.4% | 30,700 | -8.1% | 0.00% | +100.0% |
| Q3 2020 | $764,000 | +9.3% | 33,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $699,000 | +73.9% | 33,400 | +16.0% | 0.00% | 0.0% |
| Q1 2020 | $402,000 | -38.6% | 28,800 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $655,000 | +84.5% | 28,800 | -5.6% | 0.00% | – |
| Q3 2019 | $355,000 | -22.5% | 30,500 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $458,000 | +12.5% | 30,500 | +31.5% | 0.00% | 0.0% |
| Q1 2019 | $407,000 | +18.3% | 23,200 | 0.0% | 0.00% | – |
| Q4 2018 | $344,000 | -39.8% | 23,200 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $571,000 | +25.5% | 23,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $455,000 | – | 23,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |